184 related articles for article (PubMed ID: 30019149)
1. Radiotherapy for cutaneous head and neck cancer and parotid tumours: a prospective investigation of treatment-related acute swallowing and toxicity patterns.
Moroney LB; Helios J; Ward EC; Crombie J; Burns CL; Yeo SQ; Pelecanos A; Spurgin AL; Blake C; Kenny L; Chua B; Hughes BGM
Support Care Cancer; 2019 Feb; 27(2):573-581. PubMed ID: 30019149
[TBL] [Abstract][Full Text] [Related]
2. Patterns of dysphagia and acute toxicities in patients with head and neck cancer undergoing helical IMRT±concurrent chemotherapy.
Moroney LB; Helios J; Ward EC; Crombie J; Wockner LF; Burns CL; Spurgin AL; Blake C; Kenny L; Hughes BG
Oral Oncol; 2017 Jan; 64():1-8. PubMed ID: 28024718
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a speech pathology service delivery model for patients at low dysphagia risk during radiotherapy for HNC.
Moroney LB; Ward EC; Helios J; Crombie J; Burns CL; Blake C; Comans T; Chua B; Kenny L; Hughes BGM
Support Care Cancer; 2020 Apr; 28(4):1867-1876. PubMed ID: 31352509
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer. How important is dysphagia?
Roe JW; Drinnan MJ; Carding PN; Harrington KJ; Nutting CM
Oral Oncol; 2014 Dec; 50(12):1182-7. PubMed ID: 25448227
[TBL] [Abstract][Full Text] [Related]
5. 3D-conformal-intensity modulated radiotherapy with compensators for head and neck cancer: clinical results of normal tissue sparing.
Wendt TG; Abbasi-Senger N; Salz H; Pinquart I; Koscielny S; Przetak SM; Wiezorek T
Radiat Oncol; 2006 Jun; 1():18. PubMed ID: 16790059
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a weekly speech pathology/dietetic service model for providing supportive care intervention to head and neck cancer patients and their carers during (chemo)radiotherapy.
Wall LR; Cartmill B; Ward EC; Hill AJ; Isenring E; Porceddu SV
Support Care Cancer; 2016 Mar; 24(3):1227-34. PubMed ID: 26304158
[TBL] [Abstract][Full Text] [Related]
7. Organ sparing and clinical outcome with step-and-shoot IMRT for head and neck cancer: a mono-institutional experience.
Mazzola R; Ferrera G; Alongi F; Mannino M; Abbate B; Cucchiara T; Iacoviello G; Sciumè F; Di Paola G; Federico M; Blasi L; Lo Casto A; Lagalla R; Messana D
Radiol Med; 2015 Aug; 120(8):753-8. PubMed ID: 25663551
[TBL] [Abstract][Full Text] [Related]
8. Helical intensity-modulated radiotherapy with concurrent chemotherapy for oropharyngeal squamous cell carcinoma: A prospective investigation of acute swallowing and toxicity patterns.
Moroney LB; Helios J; Ward EC; Crombie J; Pelecanos A; Burns CL; Spurgin AL; Blake C; Kenny L; Chua B; Hughes BGM
Head Neck; 2018 Sep; 40(9):1955-1966. PubMed ID: 29756244
[TBL] [Abstract][Full Text] [Related]
9. Disease and toxicity outcomes for a modern cohort of patients with squamous cell carcinoma of cutaneous origin involving the parotid gland: Comparison of volumetric modulated arc therapy and pencil beam scanning proton therapy.
Zarinshenas R; Campbell P; Sun K; Molitoris JK; Patel AN; Witek ME; Cullen KJ; Mehra R; Hatten KM; Moyer KF; Taylor RJ; Vakharia KT; Wolf JS; Ferris MJ
Radiother Oncol; 2024 Apr; 193():110112. PubMed ID: 38309587
[TBL] [Abstract][Full Text] [Related]
10. Cyclical hypofractionated radiotherapy also known as "QUAD Shot" alone using intensity-modulated radiotherapy for squamous cell carcinoma of the parotid gland in an 85-year-old patient with multiple comorbidities.
Kil WJ; Camphausen K
Head Neck; 2017 Apr; 39(4):E55-E60. PubMed ID: 28170130
[TBL] [Abstract][Full Text] [Related]
11. Xerostomia: a day and night difference.
Dijkema T; Raaijmakers CP; Braam PM; Roesink JM; Monninkhof EM; Terhaard CH
Radiother Oncol; 2012 Aug; 104(2):219-23. PubMed ID: 22809589
[TBL] [Abstract][Full Text] [Related]
12. Anatomical and dose changes of gross tumour volume and parotid glands for head and neck cancer patients during intensity-modulated radiotherapy: effect on the probability of xerostomia incidence.
Marzi S; Pinnarò P; D'Alessio D; Strigari L; Bruzzaniti V; Giordano C; Giovinazzo G; Marucci L
Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):e54-62. PubMed ID: 22138192
[TBL] [Abstract][Full Text] [Related]
13. A quantitative assessment of volumetric and anatomic changes of the parotid gland during intensity-modulated radiotherapy for head and neck cancer using serial computed tomography.
Ajani AA; Qureshi MM; Kovalchuk N; Orlina L; Sakai O; Truong MT
Med Dosim; 2013; 38(3):238-42. PubMed ID: 23558146
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography number changes observed during computed tomography-guided radiation therapy for head and neck cancer.
Feng M; Yang C; Chen X; Xu S; Moraru I; Lang J; Schultz C; Li XA
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1041-7. PubMed ID: 25832695
[TBL] [Abstract][Full Text] [Related]
15. Density variation of parotid glands during IMRT for head-neck cancer: correlation with treatment and anatomical parameters.
Fiorino C; Rizzo G; Scalco E; Broggi S; Belli ML; Dell'Oca I; Dinapoli N; Ricchetti F; Rodriguez AM; Di Muzio N; Calandrino R; Sanguineti G; Valentini V; Cattaneo GM
Radiother Oncol; 2012 Aug; 104(2):224-9. PubMed ID: 22809587
[TBL] [Abstract][Full Text] [Related]
16. Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life.
Chen WC; Lai CH; Lee TF; Hung CH; Liu KC; Tsai MF; Wang WH; Chen H; Fang FM; Chen MF
Oral Oncol; 2013 Jan; 49(1):42-8. PubMed ID: 22854066
[TBL] [Abstract][Full Text] [Related]
17. Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma.
Thomson DJ; Ho KF; Ashcroft L; Denton K; Betts G; Mais KL; Garcez K; Yap BK; Lee LW; Sykes AJ; Rowbottom CG; Slevin NJ
Acta Oncol; 2015 Jan; 54(1):88-98. PubMed ID: 25279959
[TBL] [Abstract][Full Text] [Related]
18. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters.
Mortensen HR; Jensen K; Aksglæde K; Behrens M; Grau C
Radiother Oncol; 2013 Jun; 107(3):288-94. PubMed ID: 23791365
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004-03.
Toledano I; Graff P; Serre A; Boisselier P; Bensadoun RJ; Ortholan C; Pommier P; Racadot S; Calais G; Alfonsi M; Favrel V; Giraud P; Lapeyre M
Radiother Oncol; 2012 Apr; 103(1):57-62. PubMed ID: 22296746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
